Friday, November 20, 2009

Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma

Eur J Ophthalmol 2009; 19: 1029 - 1034

.
In NVG, IVB treatment can reduce iris and angle neovascularization and inhibits further PAS formation temporarily. Panretinal photocoagulation inhibits neovascularization constantly. Therefore, management of open angle NVG is more feasible with bevacizumab combined with panretinal photocoagulation.

No comments: